PLWH treated with PIs were less likely to have CD4 count greater than 200 at time of HIV diagnosis (38.6%, n = 59 vs 63.6%, n = 42; p < 0.01) or at time of cancer diagnosis (66.0%, n = 101 vs 87.9%, n = 58; p < 0.01). Here, CD4 is linked to cancer.